Primaquine Phosphate Tablets 15mg
Tablets of primaquine phosphate 15mg, an 8-aminoquinoline antimalarial from subheading note 2, used for radical cure of P. vivax relapse prevention. Dispensed in measured doses for retail under HTS 3004.60.00.00. Requires G6PD testing prior to use.
Import Duty Rates by Country of Origin
| Origin Country | MFN Rate | Ch.99 Surcharges | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | Free | — | Free |
| 🇲🇽Mexico | Free | — | Free |
| 🇨🇦Canada | Free | — | Free |
| 🇩🇪Germany | Free | — | Free |
| 🇯🇵Japan | Free | — | Free |
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If as pure heterocyclic compound
Unformulated APIs of note 2 substances classify under Chapter 29 heterocyclics.
If packaged but non-antimalarial
Retail medicaments without specific antimalarial principles use general 3004.90.
If adhesive wound dressings with added
Medicinal plasters incorporating actives classify under heading 3005.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Label with G6PD deficiency warnings mandatory; ensure child-resistant packaging
• Common issue: classifying as narcotic analog due to similar appearance
• Submit import permit for controlled substance schedules
Related Products under HTS 3004.60.00.00
Artemether-Lumefantrine Tablets
Combination tablets containing artemether and lumefantrine, both antimalarial active principles listed in subheading note 2, put up in measured doses for retail sale. Classified under HTS 3004.60.00.00 as a mixed product for therapeutic use against Plasmodium falciparum malaria. Each pack provides a full adult treatment course.
Chloroquine Phosphate Tablets 250mg
Tablets containing chloroquine phosphate, a synthetic antimalarial quinine derivative per subheading note 2, dosed at 250mg for prophylactic or treatment use. Put up in blister packs for retail sale under HTS 3004.60.00.00. Used primarily for Plasmodium vivax suppression.
Atovaquone-Proguanil Hydrochloride Tablets
Malarone-brand equivalent tablets combining atovaquone and proguanil HCl, both note 2 antimalarials, in 250mg/100mg doses for malaria prophylaxis. Retail-packed in measured doses per HTS 3004.60.00.00 as mixed therapeutic product. Suitable for travelers to endemic areas.
Quinine Sulfate Capsules 300mg
Capsules containing quinine sulfate 300mg, the canonical antimalarial alkaloid per subheading note 2, for severe falciparum treatment. Put up in measured doses for retail sale under HTS 3004.60.00.00. Also used for nocturnal leg cramps off-label.
Mefloquine Hydrochloride Tablets 250mg
Lariam-equivalent mefloquine HCl 250mg tablets, synthetic 4-quinoline methanol antimalarial listed in note 2, for weekly prophylaxis. Retail blister packs in measured doses per HTS 3004.60.00.00. Not recommended for neuropsychiatric risks.
Sulfadoxine-Pyrimethamine Tablets
Fansidar tablets combining sulfadoxine 500mg and pyrimethamine 25mg, both note 2 antimalarials, for intermittent preventive treatment. Measured doses in retail packs under HTS 3004.60.00.00. Used in pregnancy for placental malaria protection.